JP2009191034A - 時限放出製剤 - Google Patents

時限放出製剤 Download PDF

Info

Publication number
JP2009191034A
JP2009191034A JP2008035055A JP2008035055A JP2009191034A JP 2009191034 A JP2009191034 A JP 2009191034A JP 2008035055 A JP2008035055 A JP 2008035055A JP 2008035055 A JP2008035055 A JP 2008035055A JP 2009191034 A JP2009191034 A JP 2009191034A
Authority
JP
Japan
Prior art keywords
time
water
mass
drug
release preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008035055A
Other languages
English (en)
Japanese (ja)
Inventor
Hideyoshi Kanbe
英芳 神戸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP2008035055A priority Critical patent/JP2009191034A/ja
Priority to PCT/JP2008/001705 priority patent/WO2009101656A1/fr
Publication of JP2009191034A publication Critical patent/JP2009191034A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008035055A 2008-02-15 2008-02-15 時限放出製剤 Pending JP2009191034A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2008035055A JP2009191034A (ja) 2008-02-15 2008-02-15 時限放出製剤
PCT/JP2008/001705 WO2009101656A1 (fr) 2008-02-15 2008-06-30 Préparation à libération retardée

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008035055A JP2009191034A (ja) 2008-02-15 2008-02-15 時限放出製剤

Publications (1)

Publication Number Publication Date
JP2009191034A true JP2009191034A (ja) 2009-08-27

Family

ID=40956702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008035055A Pending JP2009191034A (ja) 2008-02-15 2008-02-15 時限放出製剤

Country Status (2)

Country Link
JP (1) JP2009191034A (fr)
WO (1) WO2009101656A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011207851A (ja) * 2010-03-30 2011-10-20 Asahi Kasei Chemicals Corp 膨潤性の球状核
EP2510923A1 (fr) 2011-03-30 2012-10-17 Shin-Etsu Chemical Co., Ltd. Composition de revêtement, préparation solide revêtue avec celle-ci et procédé de préparation de la formulation solide
JP2016528216A (ja) * 2013-07-25 2016-09-15 シージェイ ヘルスケア コーポレイションＣｊ Ｈｅａｌｔｈｃａｒｅ Ｃｏｒｐｏｒａｔｉｏｎ 徐放性メトホルミンと速放性ＨＭＧ−ＣｏＡ還元酵素阻害剤を含む複合製剤
WO2017115745A1 (fr) * 2015-12-28 2017-07-06 エスエス製薬株式会社 Préparation pharmaceutique obtenue par moulage par compression
JP2017529381A (ja) * 2014-10-13 2017-10-05 シージェイ ヘルスケア コーポレイションＣｊ Ｈｅａｌｔｈｃａｒｅ Ｃｏｒｐｏｒａｔｉｏｎ メトホルミン徐放性製剤及びその製造方法
JP2019099567A (ja) * 2017-11-30 2019-06-24 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188057A (ja) * 1993-12-27 1995-07-25 Ss Pharmaceut Co Ltd 粒状製剤の製造法
JPH09208458A (ja) * 1996-02-02 1997-08-12 Ss Pharmaceut Co Ltd 不快な味がマスキングされた製剤
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
WO2005092336A1 (fr) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Préparation de lessivage maîtrisé et procédé de fabrication de ladite préparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188057A (ja) * 1993-12-27 1995-07-25 Ss Pharmaceut Co Ltd 粒状製剤の製造法
JPH09208458A (ja) * 1996-02-02 1997-08-12 Ss Pharmaceut Co Ltd 不快な味がマスキングされた製剤
JP2000128779A (ja) * 1998-10-20 2000-05-09 Mitsui Chemicals Inc 薬物放出制御型製剤
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
WO2005092336A1 (fr) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. Préparation de lessivage maîtrisé et procédé de fabrication de ladite préparation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011207851A (ja) * 2010-03-30 2011-10-20 Asahi Kasei Chemicals Corp 膨潤性の球状核
EP2510923A1 (fr) 2011-03-30 2012-10-17 Shin-Etsu Chemical Co., Ltd. Composition de revêtement, préparation solide revêtue avec celle-ci et procédé de préparation de la formulation solide
JP2016528216A (ja) * 2013-07-25 2016-09-15 シージェイ ヘルスケア コーポレイションＣｊ Ｈｅａｌｔｈｃａｒｅ Ｃｏｒｐｏｒａｔｉｏｎ 徐放性メトホルミンと速放性ＨＭＧ−ＣｏＡ還元酵素阻害剤を含む複合製剤
JP2017529381A (ja) * 2014-10-13 2017-10-05 シージェイ ヘルスケア コーポレイションＣｊ Ｈｅａｌｔｈｃａｒｅ Ｃｏｒｐｏｒａｔｉｏｎ メトホルミン徐放性製剤及びその製造方法
WO2017115745A1 (fr) * 2015-12-28 2017-07-06 エスエス製薬株式会社 Préparation pharmaceutique obtenue par moulage par compression
JPWO2017115745A1 (ja) * 2015-12-28 2018-10-18 エスエス製薬株式会社 圧縮成型製剤
JP2019099567A (ja) * 2017-11-30 2019-06-24 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物
JP7336187B2 (ja) 2017-11-30 2023-08-31 日本ケミファ株式会社 多層構造を有する粒子状医薬組成物

Also Published As

Publication number Publication date
WO2009101656A1 (fr) 2009-08-20

Similar Documents

Publication Publication Date Title
JP6453380B2 (ja) ヒドロコドン放出制御製剤
JP6240279B2 (ja) 制御放出ヒドロコドン処方
JP3015105B2 (ja) 粉末被覆経口投与剤形
JP3611456B2 (ja) テオフィリン徐放性錠剤
JPH07252140A (ja) 持続性放出被覆を有する不溶性医薬品の即時放出錠剤コア
JP2007070363A (ja) 持続性放出被覆を有する不溶性医薬品の即時放出錠剤コア
KR20080059409A (ko) 즉시방출형 및/또는 조절방출형 특성을 가진 약제학적 제형
JP5667113B2 (ja) 時限放出製剤用コーティング用組成物、これによりコーティングされた時限放出固形製剤及び時限放出固形製剤の製造方法
JP2009504729A (ja) α１受容体拮抗薬の徐放性ペレット製剤及びその製造方法
CN1178659C (zh) 控释活性化合物的药物制剂
JP2013526508A (ja) ヒドロモルホンおよびナロキソンを含む医薬組成物
JPH09295933A (ja) 放出制御組成物
WO2009101656A1 (fr) Préparation à libération retardée
JP4457003B2 (ja) 放出制御医薬組成物
WO2009101658A1 (fr) Préparation pharmaceutique à libération programmée
JPH0710745A (ja) 放出開始時間制御型腸デリバリー経口製剤
Kim et al. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials
JP5070618B2 (ja) 腸溶性顆粒剤及びその製造方法
JP3466921B2 (ja) 味マスキング医薬製剤
JP4864024B2 (ja) 時限放出製剤
WO2009065130A2 (fr) Formulations à libération modifiée de diltiazème
JP3090975B2 (ja) マルチリザ−バ−型徐放性顆粒剤およびその製法
JP2003146882A (ja) 生理活性物質含有固形物の溶出速度を制御する方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Effective date: 20101110

Free format text: JAPANESE INTERMEDIATE CODE: A621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130312